Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost

Kidney Int. 2021 Dec;100(6):1334-1335. doi: 10.1016/j.kint.2021.10.006. Epub 2021 Oct 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • RNA, Messenger / genetics
  • Renal Dialysis / adverse effects
  • SARS-CoV-2
  • Vaccination
  • Vaccines*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • RNA, Messenger
  • Vaccines
  • BNT162 Vaccine